EP Patent

EP0748190A1 — Methods and formulations for use in treating benign gynecological disorders

Assigned to University of Southern California USC · Expires 1996-12-18 · 29y expired

What this patent protects

Compositions and methods which are effective to treat benign gynecological disorders for extended periods of time in women in who the risk of endometrial stimulations is minimized or absent are described, wherein an effective amount of a gonadotropin hormone releasing hormone com…

USPTO Abstract

Compositions and methods which are effective to treat benign gynecological disorders for extended periods of time in women in who the risk of endometrial stimulations is minimized or absent are described, wherein an effective amount of a gonadotropin hormone releasing hormone composition and an effective amount of an estrogenic composition are provided over a period of time, optionally with addition of an androgenic composition.

Drugs covered by this patent

Patent Metadata

Patent number
EP0748190A1
Jurisdiction
EP
Classification
—
Expires
1996-12-18
Drug substance claim
No
Drug product claim
No
Assignee
University of Southern California USC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.